Patented IP Licensing B.A.I. Biosciences holds a portfolio of more than twenty patented technologies across preventive skincare and dermatology, creating multiple licensing and co development opportunities for pharma and consumer brands. Their strong IP position can accelerate partnerships for atopic dermatitis, skin cancer prevention, and anti aging products, including white label or exclusive collaborations.

Pavise Suncare Catalyst The Pavise launch signals a dedicated platform for suncare innovation that can pair with sunscreen brands, retailers, or contract manufacturers seeking novel actives or formulations. Opportunities include joint development, licensing of Pavise enabled formulations, and private label partnerships to expand sun protection lines.

Dermatology Market Potential With a focus on common underserved skin health problems such as atopic dermatitis and aging, B.A.I. offers a pipeline for collaborations with dermatology focused brands and CROs for clinical evaluation, proof of concept, and expansion into medical or cosmetic dermatology products, leveraging Cambridge access to talent and academia.

Lean Growth Partnerships As a small to mid sized company, B.A.I. is well positioned to pursue nimble partnerships, including contract manufacturing, distribution deals, and early stage R and D collaborations to accelerate commercialization of their technologies and Pavise platform, aligning with sales cycles.

Tech Enabled BD The use of a modern tech stack and cloud based services suggests readiness for scalable operations and data driven partnerships, including digital marketing collaborations, analytics services, or data licensing related to skin health outcomes and product performance.